[1] 周天羽,李军,赖颢,等.二尖瓣修复术和二尖瓣置换术治疗感染性心内膜炎二尖瓣反流的中远期疗效比较[J].中华胸心血管外科杂志, 2017, 33(7):408-412. [2] 陈梦伟,郭新贵.高压氧联合万古霉素治疗金黄色葡萄球菌感染性心内膜炎的疗效评价[J].中华航海医学与高气压医学杂志,2017, 24(5):377-380. [3] 李吉林,侯夏凯,薛爱玲,等.氧化低密度脂蛋白诱导小鼠心脏内皮细胞炎性反应中Toll样受体2的表达[J].中国医药导报,2013, 10(35):27-30. [4] Zou JN,Xiao J,Hu SS,et al.Toll-like receptor 4 signaling pathway in the protective effect of pioglitazone on experimental immunoglobulin a nephropathy[J].Chin Med J(Engl),2017, 130(8):906-913. [5] 王恺隽,张思明,王飞燕,等.16S rRNA基因序列分析在感染性心内膜炎瓣膜内病原菌检测中的应用[J].临床检验杂志,2016, 34(7):541-543. [6] Lu CH,Tang ST,Lei YX,et al. Community-based interventions in hypertensive patients: a comparison of three health education strategies[J].BMC Public Health,2015, 15(1):33. [7] 吴梓芳,鲍翠玉,高萍萍,等.感染性心内膜炎常见病原菌分布与耐药性分析[J].中华医院感染学杂志,2015,(17):3872-3874. [8] Hiraku S,Makoto S,Hideki F,et al. TLR4, rather than TLR2, regulates wound healing through TGF-β and CCL5 expression[J].J Dermatol Sci,2014,73(2):117-124. [9] Wang Z, Qiao B,Li G,et al. Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway[J].Open Life Sci,2014,9(5):469-475. [10] Catarina CT,Emanuel O,Sousa D,et al Proceedings of the 3rd IPLeiria's International Health Congress[J].BMC Health Serv Res,2016, 16(3):56-57. [11] 徐文娟,陶志云,朱春红,等.金定鸭不同组织和血液中TLR1、TLR2、TLR4、TLR5的表达差异分析[J].中国畜牧兽医,2017, 44(12):3459-3465. [12] Strand MA, Gramith K, Royston M,et al.A community-based cross-sectional survey of medication utilization among chronic disease patients in China[J].Int J Pharm Pract,2017, 25(5):78-79.